• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Biol . Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells

tetano

Editor, Senior Moderator
PLoS Biol


. 2022 Aug 1;20(8):e3001728.
doi: 10.1371/journal.pbio.3001728. Online ahead of print.
Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells


Yanshan Zhu[SUP] 1 [/SUP], Keng Yih Chew[SUP] 1 [/SUP], Melanie Wu[SUP] 1 [/SUP], Anjana C Karawita[SUP] 1 [/SUP], Georgina McCallum[SUP] 1 [/SUP], Lauren E Steele[SUP] 1 [/SUP], Ayaho Yamamoto[SUP] 2 [/SUP], Larisa I Labzin[SUP] 3 [/SUP], Tejasri Yarlagadda[SUP] 4 [/SUP], Alexander A Khromykh[SUP] 1 5 [/SUP], Xiaohui Wang[SUP] 3 [/SUP], Julian D J Sng[SUP] 1 [/SUP], Claudia J Stocks[SUP] 3 [/SUP], Yao Xia[SUP] 6 7 [/SUP], Tobias R Kollmann[SUP] 8 9 [/SUP], David Martino[SUP] 10 [/SUP], Merja Joensuu[SUP] 9 11 12 [/SUP], Frédéric A Meunier[SUP] 11 13 [/SUP], Giuseppe Balistreri[SUP] 13 14 [/SUP], Helle Bielefeldt-Ohmann[SUP] 1 5 [/SUP], Asha C Bowen[SUP] 8 15 16 17 [/SUP], Anthony Kicic[SUP] 10 18 19 [/SUP], Peter D Sly[SUP] 2 5 [/SUP], Kirsten M Spann[SUP] 4 [/SUP], Kirsty R Short[SUP] 1 5 [/SUP]



Affiliations

Abstract

Children typically experience more mild symptoms of Coronavirus Disease 2019 (COVID-19) when compared to adults. There is a strong body of evidence that children are also less susceptible to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection with the ancestral viral isolate. However, the emergence of SARS-CoV-2 variants of concern (VOCs) has been associated with an increased number of pediatric infections. Whether this is the result of widespread adult vaccination or fundamental changes in the biology of SARS-CoV-2 remain to be determined. Here, we use primary nasal epithelial cells (NECs) from children and adults, differentiated at an air-liquid interface to show that the ancestral SARS-CoV-2 replicates to significantly lower titers in the NECs of children compared to those of adults. This was associated with a heightened antiviral response to SARS-CoV-2 in the NECs of children. Importantly, the Delta variant also replicated to significantly lower titers in the NECs of children. This trend was markedly less pronounced in the case of Omicron. It is also striking to note that, at least in terms of viral RNA, Omicron replicated better in pediatric NECs compared to both Delta and the ancestral virus. Taken together, these data show that the nasal epithelium of children supports lower infection and replication of ancestral SARS-CoV-2, although this may be changing as the virus evolves.
 
Back
Top Bottom